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Abstract 
Background: Anxiety disorders are common in childhood, adolescence, and adulthood, and 
frequently comorbid with other mental disorders. 
Objective: The main aim of the present study was to examine the incidence, recurrence and 
comorbidity rates of anxiety disorders across four developmental periods, namely, during 
childhood (5 – 12.9 years), adolescence (13 – 17.9 years), emerging adulthood (18 – 23.9 years), 
and adulthood (24 – 30 years). 
Method: Eight hundred and sixteen participants from a large community sample were 
interviewed twice during adolescence, at age 24, and at age 30. They completed self-report 
measures of psychosocial functioning and semi-structured diagnostic interviews during 
adolescence and adulthood. 
Results: The result showed first incidence of anxiety disorders to be significantly higher in 
childhood and adulthood than in adolescence and emerging adulthood. Female gender was 
associated with first incidence, but not with recurrence. The magnitude of comorbidity was 
comparable across the four developmental stages, except for Substance use disorders (SUD) 
during adolescence. The presence of anxiety disorders during childhood and adolescence was 
found to significantly increase the probability of having an anxiety disorder during emerging 
adulthood. 
Limitations: The participants are ethically and geographically homogenous. 
Conclusion: Incidence and recurrence rates of anxiety disorders differed across the 
developmental periods, but no difference was found for the comorbidity rates.  
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1.   Introduction 
There is persuasive evidence that anxiety disorders are the most frequent psychiatric 
disorders in childhood, adolescence, and adulthood. Up to 12% of children and up to 32% of 
adolescents and adults in the community are estimated to have been diagnosed with any anxiety 
disorders (Essau, 2005; Feehan et al., 1993; Lewinsohn et al., 1997; Merikangas et al., 2010; 
Wittchen et al., 1998). In addition to being highly prevalent, anxiety disorders tend to co-occur 
frequently both among themselves and with numerous other psychiatric disorders such as with 
depressive and substance use disorders (Essau et al., 2000; Feehan et al., 1993; Lewinsohn et al., 
1997; Wittchen et al., 1998). Studies have also reported that more females than males meet the 
diagnosis of anxiety disorders, with gender differences occurring as early as childhood and 
reaching ratios of 2:1 to 3:1 in adolescence. 
Most anxiety disorders tend to have an early onset, generally in childhood or early 
adolescence. If left untreated, anxiety disorders that begin early in life can become chronic 
(Essau et al., 2014; Feehan et al., 1993; Ferdinand and Verhulst, 1995; Keller et al., 1992; 
Letcher et al., 2012; Pine et al., 1998) and are associated with a high probability of recurrence 
(Bruce et al., 2005). The presence of anxiety disorders during adolescence also predicted a two to 
three-fold increased risk for anxiety disorders in adulthood (Pine et al., 1998). A recent study by 
Copeland et al. (2014) showed that 22.7% of their participants had met criteria for any anxiety 
disorders by early adulthood; this prevalence rate increased to 27.0% if overanxious disorder was 
included in the analyses. Their result also showed childhood anxiety disorders to be associated 
with adverse functioning in at least one life domain during young adulthood. Essau and 
colleagues (2014) recently examined the associations between anxiety disorders with an onset in 
two developmental periods (during childhood and adolescence) and psychosocial outcomes at 
age 30. In that report, adolescent-onset anxiety disorder was associated with more negative 
course and outcome than childhood-onset anxiety disorder. Specifically, adolescent-onset 
anxiety disorder predicted poorer total adjustment, poorer adjustment at work, poorer family 
relationships, problems with the family unit, less life satisfaction, poorer coping skills, and more 
chronic stress in adulthood than those with childhood anxiety. Adolescent-onset anxiety disorder 
also predicted substance (SUD), alcohol abuse/dependence (AUD), and anxiety disorder in 
adulthood.  
Although large longitudinal studies have enhanced our knowledge regarding the 
prevalence, comorbidity, and course and outcome of anxiety disorders in children, adolescents 
and adults, little is known about these characteristics of anxiety in emerging adults. Emerging 
adulthood is a developmental stage that spans between adolescence and adulthood (Arnett, 
2000), which is characterized by significant psychological changes (e.g., autonomy, identity 
exploration) and distinct psychosocial events (e.g., residence [i.e., independent living], social 
role [e.g., getting married], and career pursuits [i.e., employment]).These changes are associated 
with stressors that are associated with both risk and opportunities for growth, which in turn could 
have a significant impact in mental health (Schulenberg et al., 2004). 
On the basis of this general background, the present study reports the results of a 16-year 
longitudinal study and compares the incidence, recurrence and comorbidity rates of anxiety 
disorders in childhood, adolescence, emerging adulthood, and adulthood. The more specific aims 
are to address the following four questions. In each of these developmental stages: (a) what are 
the incidence and recurrence rates of anxiety disorders?; (b) what are the effects of gender on 
anxiety disorders?; (c) how frequently do anxiety disorders co-occur with depressive and 
substance use disorders?; and (d) do anxiety disorders that are present in a prior developmental 
stage predict subsequent anxiety? 
The hypotheses to be tested in this study were as follows: First, the highest incidence rate 
is hypothesized to be found during emerging adulthood; recurrence rate is expected to be the 
highest during adulthood (Scholten et al., 2016; Scholten et al., 2013). Second, females 
compared to males are expected to have significantly higher incidence and recurrence rates of 
anxiety disorders. Female gender is also expected to predict the recurrence of anxiety in any 
developmental stages (McLean et al., 2011). Third, in all developmental stages, there will be a 
strong association between anxiety and major depression, and between anxiety and substance use 
disorders (Essau et al., 2000; Lewinsohn et al., 1997; Wittchen et al., 1998). Fourth, the presence 
of an anxiety disorder at one developmental disorder will increase the risk of having an anxiety 
disorder in the subsequent developmental period (Essau et al., 2014; Pine et al., 1998).  
 To our knowledge, this is the first study that has compared the incidence, recurrence and 
comorbidity of anxiety disorders in childhood, adolescence, emerging adulthood, and adulthood 
with the same sample of individuals.  
 
2.  Methods 
2.1.  Participants 
The present study used data from the Oregon Adolescent Depression Project (OADP; 
Lewinsohn et al., 1993), a longitudinal study of a large cohort of high school students who were 
randomly selected from nine high schools in western Oregon; detailed information about the 
OADP had been reported elsewhere (Lewinsohn et al., 2003; Pettit et al., 2006; Rohde et al., 
2007). A total of 1709 adolescents (ages 14–18; mean age 16.6, SD=1.2) completed the initial 
(T1) assessments who were invited to participate in the second assessment. About a year later, 
1507 adolescents participated at time 2 (T2; 88%). For the third assessment (T3), all adolescents 
with a history of a depressive disorder by T2 (n=360) or a history of non-mood disorders 
(n=284), and a random sample of adolescents with no history of psychopathology by T2 (n=457) 
were invited to participate in a third (T3) evaluation. In addition, all non-white T2 participants 
were retained in the T3 sample to maximize ethnic diversity. A total of 1101 young adults 
participated at time 3 (T3), with a mean age of 24.2 years. At age 30, all T3 participants were 
asked to complete another interview assessment (mean age=30.45, SD=.70). Of the 941 who 
participated in the T3 assessment, 816 (87%) completed the T4 assessment. 
 Of these 816 individuals, 58.8% of the sample were female, with a mean age at T4 of 
30.45 years (SD=0.70). Most participants were White (85.9%), others were African American 
(1%), Hispanic (3%), American Indian (3%), Asian (3%), and “other” (2%). About half of the 
sample was married (56.2%), and 41% had a bachelor’s degree or higher by T4. 
 
2.2. Measures 
2.2.1. Diagnostic measures 
Participants were interviewed with the Schedule for Affective Disorders and 
Schizophrenia for School-Age Children (K-SADS; Orvaschel et al., 1982) at T1 and T2. For the 
follow-up assessments at T2 and T3, the participants were also administered with the 
Longitudinal Interval Follow-Up Evaluation (LIFE; Keller et al., 1987). The K-SADS/LIFE was 
used to collect information regarding the onset and course of disorders since the previous 
interview. The T4 interview consisted of a joint administration of the LIFE and the Structured 
Clinical Interview for DSM-IV (SCID; First et al., 1996) to collect information for new or 
continuing episodes since T3. Diagnoses were based on DSM-III-R criteria for T1 and T2 and 
Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV; American 
Psychiatric Association, 1994) criteria for T3 and T4. 
The anxiety disorder diagnostic category included generalized anxiety disorder, 
overanxious disorder, post-traumatic stress disorder, panic disorder, agoraphobia, social phobia, 
simple phobia, obsessive–compulsive disorder, and separation anxiety disorder. Substance use 
disorders (SUD) included alcohol abuse or dependence (AUD) and sedative/hypnotic/anxiolytic, 
cannabis, stimulant, opioid, cocaine, and hallucinogen/PCP abuse or dependence, and polydrug 
dependence. Disruptive disorder included attention deficit and hyperactivity disorder, 
oppositional defiant disorder and conduct disorder. The interrater reliability for depressive 
disorders (MDD or dysthymia) in the four time assessments, with Kappa ranging from 0.82 to 
1.00; for anxiety disorders it ranged from 0.76 to 0.87; and for SUD from 0.81 to 0.96. 
 
2.2.2. Statistical procedures 
First incidence, recurrence, and total incidence were calculated using descriptive statistics 
and corresponding 95% confidence intervals. To investigate the extent to which gender 
(1=female, 0=male) predicted rates of anxiety, binary logistic regression models were used. 
Binary regression models were also used to examine the comorbidity between anxiety with 
depression and SUD. Because of the frequent comorbidity between SUD and disruptive 
behaviour disorders, comorbidity with SUD were both unadjusted and adjusted for the presence 
of disruptive behaviour disorders. 
 
 
3.  Result 
3.1. Incidence and recurrence rates of anxiety disorders 
Table 1 shows the first incidence (i.e., number of participants with first episodes of 
anxiety at each developmental stage), recurrent (i.e., number of participants with previous 
anxiety disorders in the previous developmental period and who have a new anxiety episode), 
and total incidence (i.e., number of cases in a developmental stage with either a first incidence or 
a recurrence). Following Rohde et al. (2012), the dominator for each of the developmental stage 
was calculated as follows: childhood (5.0 – 12.9 years) included all the participants (N=816), 
during the adolescence (13.0 – 17.9 years) there were 741 participants (816 minus 75), during 
emerging adulthood (18.0 – 23.9 years) there were 707 participants (816 minus 109), and during 
adulthood (24- 30 years), the number of participants were 671 (816 minus 145). 
Significant differences in the incidence of anxiety disorders emerged across the four 
developmental stages. First incidence rates of anxiety disorders were significantly higher in 
childhood and adulthood than in adolescence and emerging adulthood. This higher incidence rate 
was related to separation anxiety in childhood, and to panic disorder in adulthood. Recurrence of 
anxiety disorders were found in adolescence, emerging adulthood, and adulthood, with 
comparable rates across these three developmental stages. The total incidence was significantly 
higher in adulthood than the other three developmental stages where comparable rates were 
found. 
 
3.2. Gender and anxiety disorders 
The next step of our analysis was to examine the extent to which gender predict the rates 
of anxiety disorders across the four developmental periods, using univariate logistic regression. 
As shown on Table 2, female gender was associated with first and total incidence in childhood, 
emerging adulthood and adulthood, but not in adolescence.  
The odds ratios for the recurrence of anxiety disorders were not significant in 
adolescence and emerging adulthood, suggesting that female gender did not predict recurrence 
during these two developmental stages.  
 
3.3. Comorbidity of anxiety disorders 
Table 3 shows the comorbidity between anxiety disorders with MDD and SUD. The 
comorbidity between anxiety disorders and SUD was examined first irrespective of the presence 
of disruptive behavioural disorder, and then by controlling for the presence of disruptive 
behavioural disorders. Significant comorbidity was found between anxiety disorders and MDD 
across developmental periods; the magnitude of comorbidity across periods was comparable, and 
indicated a four-fold increase in risk. The comorbidity between anxiety and SUD was significant 
across three of the four developmental periods (non-significant in the adolescent period), 
regardless of whether or not the presence of disruptive behavioural disorder was being 
controlled.  
 
3.4. Impact of prior anxiety disorders 
The degree to which the presence of anxiety disorders during an earlier developmental 
period influenced the risk of having an anxiety during a later developmental period was also 
examined. Following Rohde et al. (2013), we examined the extent to which the rate of anxiety 
disorders in adolescence was a function of MDD in childhood; emerging adulthood was a 
function of MDD in either childhood or adolescence; and adulthood was a function of MDD in 
childhood, adolescence, or emerging adulthood. During adolescence, the probability of having an 
anxiety disorder given childhood anxiety was 8% (OR=2.26, 95% CI [0.91, 5.62]). During 
emerging adulthood, the probability of having an anxiety disorder given an anxiety during 
childhood or adolescence was 9% (OR=2.20, 95% CI [1.05-4.63]). During adulthood, the 
probability of having an anxiety disorder given an anxiety during childhood, adolescence, or 
emerging adulthood was 8% (OR=1.13, 95% CI [0.62-2.09]). 
 
4. Discussion 
The present study makes a significant contribution to our understanding of anxiety 
disorders by providing information on their incidence and recurrence rates and comorbidity 
patterns in childhood, adolescence, emerging adulthood, and adulthood in a large non-patient 
sample. This was made possible by following a large cohort of adolescents into adulthood. Four 
major findings were obtained. 
First, the incidence rates of anxiety disorders were significantly higher in childhood and 
adulthood than the other two developmental stages. The higher incidence rate was related to the 
presence of separation anxiety in childhood, and to panic disorder in adulthood. The higher 
incidence of separation anxiety in childhood compared to other developmental stages supports 
previous studies that showed this disorder to have its first onset in childhood and is the earliest 
onset of all anxiety disorders (Beesdo et al., 2009); it also provides support to the finding that 
separation anxiety disorder is the most frequent anxiety disorder among children, with 
prevalence rates ranging from 2.8% to 8% (Beesdo et al., 2009; Bowen et al., 1990; Pine et al., 
1998). Furthermore, the higher incidence of panic disorder in adulthood was in line with 
previous studies that reported this disorder to have its first onset in adulthood (de Graaf et al., 
2003; Kessler et al., 2005).  
Our hypothesis that emerging adulthood would have the highest incidence of anxiety 
disorders was not supported. This was surprising given major life changes and stressors (e.g., 
relationship instability, lack of economic independence) that are often reported during this 
developmental stage which could put individuals at this stage at risk of developing an anxiety 
disorder (Schulenberg et al., 2004). However, it is worth noting that the concept of emerging 
adulthood is controversial, with some authors considering this concept to be better 
conceptualized in terms of economic conditions instead of a psychological developmental period 
(Côté and Bynner, 2008).  
Second, the incidence of anxiety disorders is significantly higher in females than males 
during childhood, emerging adult, and adulthood. This finding replicates previous studies (Essau 
et al., 2000; Hale et al., 2008; Letcher et al., 2012; Merikangas et al., 2010; Pine et al., 1998; 
Reinherz et al., 1989) showing higher rate of anxiety disorders among females than males; 
previous studies have reported gender differences during childhood and then increase with age 
which reach ratios of 2:1 to 3:1 in adolescence (Pine et al., 1998) . Interestingly, no gender 
differences were found for first incidence of anxiety disorders during adolescence which is 
inconsistent with previous studies (Pine et al., 1998). While it is beyond the scope of the present 
study to explore the reason for this non-significant gender difference during this specific 
developmental stage, it could be related to the biological changes related to puberty which have 
similar impact on boys and girls. 
Third, in agreement with previous studies (Essau et al., 2000; Kashani and Orvaschel, 
1990; Last et al., 1997; Lewinsohn et al., 1997; Rohde et al., 1991), the degree of comorbidity 
between anxiety disorders and MDD, as well as between anxiety and SUD were significant; to 
our knowledge the present study was the first to have examined the comorbidity between 
anxiety, MDD and SUD across the four developmental periods where comparable comorbidity 
rates were found, except for SUD during adolescence. Despite the high comorbidity rates 
between anxiety and other psychiatric disorders, the meaning of comorbidity for 
psychopathology issues remains unclear. One explanation could be related to our current 
classification and assessment of psychiatric disorders (Merikangas, 1990). Another explanation 
is related to the etiology of disorders. As argued by Merikangas (1990), the co-occurrence of 
disorders could be etiologic in that one disorder causes the second disorder, or that the two 
disorders are manifestations of the same underlying etiologic factors. 
Fourth, the presence of anxiety disorders during childhood and adolescence was found to 
significantly increase the probability of having an anxiety during emerging adulthood. Indeed, 
several longitudinal studies have shown that young people with anxiety disorders compared with 
those without this disorder are at increased risk to have the same disorder (Bittner et al., 2007; 
Newman et al., 1996; Pine et al., 1998) at follow-up (‘‘homotypic continuity’’). Moreover, 
studies among adults have reported that those with anxiety disorders often had these same 
disorders during adolescence (Gregory et al., 2007). 
 
5. Limitations 
 The study has some limitations which should be considered. First, the extent to which our 
findings are generalizable to other populations is unknown because the sample was restricted to 
one geographical location of the United States. Related to this limitation is the fact that the 
sample was predominantly of European-American descent. Second, given differences in 
prevalence of anxiety disorders across ethnic groups, the generalizability of the present findings 
may be limited (Asnaani et al., 2010). Third, the OADP is a 16-year longitudinal study, and as 
such changes in the diagnostic criteria and assessment approaches used are inevitable; 
furthermore, there are some attrition at each assessment. Fourth, the information related to the 
diagnoses were assessed solely via self-report. Finally, similar to other longitudinal studies (e.g., 
Essau et al., 2002), the drop-out rate was high which was not surprising because the participants 
were followed over the period of 16 years. 
  
6. Conclusions  
The first incidence rates of anxiety disorders differ across the four developmental stages, 
and the presence of anxiety disorders during an earlier developmental period tended to increase 
the probability of having an anxiety during a later developmental period.  Studies are needed to 
elucidate the social, psychological, and physiological processes that give rise to the differences 
in the incidence rates across developmental stages. A better understanding of these processes will 
likely play a crucial role in designing effective prevention programs for individuals in specific 
developmental stages. 
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 Table 1  Rates of specific types of anxiety disorders during the four developmental periods 
 Child 
N (%)         [95% CI] 
Adolescent 
N (%)        [95% CI] 
Emerging adult 
N (%)       [95% CI] 
Adulthood 
N (%)      [95% CI] 
First incidence  
(total anxiety) 
SepAnx 
Phobia 
Agoraphobia 
Social phobia 
Specific phobia 
GAD 
OCD 
Panic 
Panic with Agora 
Panic without Agora 
 
75 (7)         [5.2,  8.3] 
34 (0.03)    [0.02,  0.04] 
23 (0.02)    [0.01,  0.03] 
1 (0.00)      [0.00, 0.00] 
14 (0.012)  [0.01, 0.02] 
0 (00)         [0.0,  0.0] 
0 (00)         [0.0,  0.0] 
3 (0.003)    [0.00, 0.01] 
4 (0.35)      [0.00,  0.70] 
2 (0.002)    [00,  0.004] 
2 (0.002)    [0.0,  0.004] 
 
34 (4)        [2.3,  4.8] 
2 (0.002)   [0.00,  0.004] 
16 (0.02)   [0.01,  0.03] 
0 (00)       [0.0,  0.0] 
6 (0.01)    [0.001,  0.01] 
7 (0.01)    [0.001,  0.01] 
0 (00)       [0.0,  00] 
3 (0.003)   [0.00,  0.01] 
9 (0.88)     [0.30,  1.50] 
4 (0.004)   [0.0,  0.01] 
5 (0.004)   [0.001,  0.01] 
 
36 (4)       [2.7,  5.5] 
0 (00)       [0.0,  00] 
10 (0.01)  [0.004,  0.02] 
4 (0.001)  [0.0,  0.01] 
5 (0.005)  [0.00,  0.01] 
3 (0.003)  [0.0,  0.01] 
1 (0.001)  [0.00, 0.00] 
0.00 (00)  [0.00,  0.00] 
17 (1.60)  [0.80,  2.40] 
3 (0.003)   [0.0,  0.01] 
14 (0.01)   [0.01,  0.02] 
 
46 (7)       [4.6,  8.4] 
0 (00)       [0.0,  0.0] 
16 (0.02)  [0.01,  0.03] 
0 (00)       [0.0,  0.0] 
10 (0.01)  [0.004,  0.02] 
11 (0.01)   [0.001,  0.02] 
17 (0.02)  [0.01,  0.03] 
5 (0.004)  [0.001,  0.01] 
27 (3.10)  [1.90,  4.30] 
10 (0.01)   [0.004,  0.02] 
17 (0.02)    [0.01,  0.03] 
PTSD 
Acute stress 
18 (0.02)    [0.01,  0.03] 
0 (00)       [00,  00] 
11 (0.01)   [0.004,  0.02] 
0 (00)       [00,  00] 
29 (0.03)  [0.02,  0.04] 
1 (0.001)  [00,  0.003] 
12 (0.01)  [0.01,  0.02] 
0 (00)       [00,  00] 
Recurrence  
(total anxiety) 
SepAnx 
Phobia 
Agoraphobia 
Social phobia 
Specific phobia 
GAD 
OCD 
Panic 
Panic with Agora 
Panic without Agora 
PTSD 
Acute stress 
 
0 (00)         [0.0,  0.0] 
0 (00)         [0.0,  0.0] 
0 (00)         [0.0,  0.0] 
0 (00)         [0.0,  0.0] 
0 (00)         [0.0,  0.0] 
0 (00)         [0.0,  0.0] 
0 (00)         [0.0,  0.0] 
0 (00)         [0.0,  0.0] 
0 (00)         [0.0,  0.0] 
0 (00)         [0.0,  0.0] 
0 (00)         [0.0,  0.0] 
0 (00)         [0.0,  0.0] 
0 (00)         [0.0,  0.0] 
   
6 (8)          [1.7,  13.8] 
1 (0.03)     [0.00,  0.09] 
0 (00)         [0.0,  0.0] 
0 (00)         [0.0,  0.0] 
0 (00)         [0.0,  0.0] 
0 (00)         [0.0,  0.0] 
0 (00)         [0.0,  0.0] 
0 (00)         [0.0,  0.0] 
0 (00)         [0.0,  0.0] 
0 (00)         [0.0,  0.0] 
0 (00)         [0.0,  0.0] 
1 (0.05)     [0.00,  0.15] 
0 (00)         [0.0,  0.0] 
 
10 (9)       [3.5,  13.9] 
0 (00)         [0.0,  0.0] 
0 (00)         [0.0,  0.0] 
0 (00)         [0.0,  0.0] 
0 (00)         [0.0,  0.0] 
0 (00)         [0.0,  0.0] 
0 (00)         [0.0,  0.0] 
0 (00)         [0.0,  0.0] 
1 (7.12)      [0.00,  21.2] 
1 (0.14)      [0.0,  0.43] 
0 (00)         [0.0,  0.0] 
1 (0.03)      [0.00,  0.09] 
0 (00)         [0.0,  0.0] 
 
12 (8)       [3.4, 11.8] 
0 (00)         [0.0,  0.0] 
0 (00)         [0.0,  0.0] 
0 (00)         [0.0,  0.0] 
0 (00)         [0.0,  0.0] 
0 (00)         [0.0,  0.0] 
0 (00)         [0.0,  0.0] 
0 (00)         [0.0,  0.0] 
1 (3.12)      [0.00,  9.20] 
0 (00)         [0.0,  0.0] 
1 (0.05)    [0.00,  0.14] 
1 (0.02)    [0.00,  0.05] 
0 (00)         [0.0,  0.0] 
Total incidence 
(total anxiety) 
SepAnx 
Phobia 
Agoraphobia 
Social phobia 
Specific phobia 
GAD 
OCD 
Panic 
Panic with Agora 
Panic without Agora 
PTSD 
Acute stress 
 
75 (7)         [5.2,  8.3] 
34 (0.03)    [0.02,  0.04] 
23 (0.02)    [0.01,  0.03] 
1 (00)         [0.0,  0.0] 
14 (0.01)    [0.01,  0.02] 
0 (00)         [0.0,  0.0] 
0 (00)         [0.0,  0.0] 
3 (0.003)   [0.00,  0.01] 
4 (0.35)     [0.00,  0.70] 
2 (0.002)    [0.0,  0.004] 
2 (0.002)    [0.0,  0.01] 
18 (0.02)   [0.01,  0.03] 
0 (00)         [0.0,  0.0] 
 
40 (4)        [2.6,  5.1] 
3 (0.003)   [0.00,  0.006] 
16 (0.02)   [0.01,  0.03] 
0 (00)         [0.0,  0.0] 
6 (0.01)      [0.001,  0.01] 
7 (0.01)      [0.001,  0.01] 
0 (00)         [0.0,  0.0] 
3 (0.003)   [0.00,  0.01] 
9 (0.88)     [0.30,  1.50] 
4 (0.004)   [0.0,  0.01] 
5 (0.004)   [0.001,  0.01] 
12 (0.01)   [0.01,  0.02] 
0 (00)         [0.0,  0.0] 
 
46 (5)         [3.2,  6] 
0 (00)         [0.0,  0.0] 
10 (0.01)    [0.00,  0.02] 
4 (00)         [0.0,  0.01] 
5 (0.01)      [0.0,  0.01] 
3 (0.003)    [0.0,  0.01] 
1 (0.001)    [0.00,  0.00] 
0 (00)         [0.0,  0.0] 
18 (1.67)    [0.90,  2.50] 
4 (0.00)      [0.0,  0.01] 
14 (0.01)    [0.01,  0.02] 
30 (0.03)    [0.02,  0.04] 
1 (0.001)  [00,  0.003] 
 
58 (7)       [4.9,  8.4] 
0 (00)         [0.0,  0.0] 
16 (0.02)   [0.01,  0.03] 
0 (00)         [0.0,  0.0] 
10 (0.01)    [0.004,  0.02] 
11 (0.01)    [0.004,  0.02] 
17 (0.02)   [0.01,  0.03] 
5 (0.004)   [0.001,  0.01] 
28 (3.10)   [1.90,  4.30] 
10 (0.01)    [0.01,  0.02] 
18 (0.02)    [0.01,  0.03] 
13 (0.01)   [0.01,  0.02] 
0 (00)         [0.0,  0.0] 
 
Note: SepAnx = Separation Anxiety Disorder; GAD = Generalised Anxiety Disorder; OCD = Obsessive-Compulsive Disorder; Panic 
with Agora = Panic disorder with Agoraphobia; Panic without Agora = Panic disorder without Agoraphobia; PTSD = Post-traumatic 
Stress Disorder.  OR = odds ratio; CI = confidence interval. 
Table 2   Gender predicting anxiety disorders during the four developmental periods 
 
Disorders Child 
OR      [95% CI] 
Adolescent 
OR      [95% CI] 
Emerging adult 
OR      [95% CI] 
Adulthood 
OR       [95% CI] 
 
First incidence 
 
2.95    [1.67,  5.10]*** 
 
2.07    [0.89,  4.85] 
 
2.48    [1.10,  5.61]* 
 
2.15     [1.08,  4.28]* 
Recurrence - 1.45    [0.16,  13.36] 1.32    [0.26,  6.70] - 
Total incidence 2.95    [1.67,  5.18]*** 2.12    [0.96,  4.69] 2.43    [ 1.17, 5.03]* 2.42     [1.26, 4.68]** 
 
Note:  OR = odds ratio; CI = confidence interval. For child, there is no recurrence, thus, the OR cannot be computed. 
For adult, none of the male participants had any recurrence, thus the OR cannot be computed. 
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Table 3  Period comorbidity of anxiety disorders during the four developmental periods 
 
Disorders Child 
%              OR         [95% CI] 
Adolescent 
%               OR       [95% CI] 
Emerging adult 
%              OR       [95% CI] 
Adulthood 
%              OR        [95% CI] 
 
Major depression 
 
16 v 4     4.59    [2.29,  9.20] 
 
64 v 29      4.31    [2.61,  7.14] 
 
57 v 28     3.53    [1.98,  6.30] 
 
60 v 24     4.74     [2.77, 8.10] 
Substance disordera   5 v 1     4.40    [1.37,  14.15] 28 v 22      1.35    [0.80,  2.29] 42 v 28     1.90    [1.08,  3.38] 34 v 18     2.31     [1.33, 4.01] 
Substance disorderb   4 v 1     4.59    [1.43,  14.66] 26 v 20      1.43    [0.83,  2.47] 44 v 47     1.87    [ 1.04, 3.34] 35 v 17     2.34     [1.34, 4.10] 
 
Note: Childhood, 5.0–12.9 years of age; adolescence, 13.0–17.9 years of age; emerging adulthood, 18.0–23.9 years of age; adulthood, 
24–30 years of age.  
Percentages (%) represent anxiety disorders vs. no anxiety disorders. All tests significant at p < .001. OR = odds ratio; CI = 
confidence interval. 
aUnadjusted associations.  bAdjusted for the lifetime presence of disruptive behavior disorders. 
 
 
